mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.0005 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.002 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |